Facebook Instagram Linkedin Twitter Website
Home Blog Page 140

ORGANO Expands Africa Footprint into South Africa

By
IHR Magazine
-
0
ORGANO Expands Africa Footprint into South Africa

ORGANO announced it has formally expanded its Africa footprint into South Africa. The new market opened on 6 October and is now accepting customer orders and new distributor applications.

The ORGANO African Headquarters and logistics hub are located in Johannesburg.

“Our opening in South Africa represents another achievement in expanding ORGANO throughout the African Continent and is an important component of our strategic growth plan for the EMEA region,” said ORGANO Managing Director of Global Strategy, Leonard Chin. “The ORGANO brand is one of the most well known and respected brands in the global nutrition industry. This historic new market opening brings the ORGANO product lineup to millions of Africans who enjoy great tasting and healthy nutritional foods and beverages,” added Chin.

As in most markets around the world, ORGANO offers a lineup of its beverages and specialty nutritional products in South Africa.

“This latest entry into Africa represents a long term commitment to the people of Africa through our Continental Africa Plan, our broader regional growth strategy for EMEA and our global plan to make ORGANO products more broadly available around the world,” said ORGANO Chief Operating Officer, Norm Perrett.

About ORGANO
Founded in 2008 with headquarters in Vancouver, British Columbia, and formerly known as Organo Gold, ORGANO is one of the world’s leading producers and marketers of healthy, convenient and affordable nutrition and beauty products. ORGANO specializes in proprietary nutrition products, specialty brewed beverages, personal care products and cosmetics. ORGANO provides superior quality, taste and nutrition in all of its consumable products and produces and markets advanced beauty products based on proprietary botanical formulations. The company currently operates in five continents.

Cautionary Statement
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which contain words such as “expect,” “believe,” “will,” “anticipates,” “believes,” “estimates,” or “plan,” by their nature address matters that are, to different degrees, uncertain. These uncertainties may cause actual future events to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.

For more information on ORGANO and the Joint Venture, please go to http://www.organogold.com.-CNW

Publix Announces Quarterly Dividend

By
IHR Magazine
-
0
Publix Announces Quarterly Dividend

Publix Super Markets Inc. announced its board of directors declared a quarterly dividend of 26 cents per share on its common stock.

The dividend will be payable Aug. 1, 2018, either through direct deposit or mailed as a check to stockholders of record as of the close of business July 13, 2018.

Visit corporate.publix.com/stock to elect direct deposit of dividends. For individual, joint or custodial accounts, click Publix Stockholder Online at the bottom of the page. After registering for a secure and confidential online account, log in and select Dividends > Payment Preferences to elect direct deposit.

Direct deposit elections also can be made by completing the online Direct Deposit Authorization for Publix Stock Dividends form at corporate.publix.com/stock > Stockholder Resources > Forms. Print and sign the form as indicated, and then send it with a voided check to Publix stockholder services.

Publix is privately owned and operated by its more than 190,000 employees, with 2017 sales of $34.6 billion. Currently, Publix has 1,187 stores in Florida, Georgia, Alabama, Tennessee, South Carolina, North Carolina and Virginia. The company has been named one of Fortune’s 100 Best Companies to Work For in America for 21 consecutive years. In addition, Publix’s dedication to superior quality and customer service is recognized among the top in the grocery business. For more information, visit the company’s website, corporate.publix.com. —BusinessWire

Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabis Skin Care

By
IHR Magazine
-
0
Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabis Skin Care

Cronos Group Inc., announced today that it has entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion – Israel Institute of Technology (“Technion“) to explore the use of cannabinoids and their role in regulating skin health and skin disorders. The preclinical studies will be conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair.

The research will be led by Technion faculty members Dr. David “Dedi” Meiri, Head, Laboratory of Cancer Biology and Cannabinoid Research and Dr. Yaron Fuchs, Head, Laboratory of Cancer Biology and Cannabinoid Research, two of the world’s leading researchers in cannabis and skin stem cell research, respectively. Dr. Meiri heads the Laboratory of Cannabis and Cancer Research with vast experience in cannabis and endocannabinoid research. Dr. Fuchs heads the Laboratory of Stem Cell Biology and Regenerative Medicine with years of experience in the biology of the skin and its pathologies. Development and implementation of the research will be conducted at Technion’s Laboratory of Cancer Biology and Cannabis Research and the Lorry I. Lokey Interdisciplinary Center of Life Sciences and Engineering in Haifa, Israel.

“We believe that the potential applications of cannabinoids to regulate skin health and treat skin disorders are vast, and we are excited to begin exploring these applications through our partnership with Technion,” said Mike Gorenstein, CEO of Cronos Group. “Using rigorous data to develop efficacious topical and transdermal formulations will be key to creating differentiated products that provide quality treatments to our consumers and strengthen our brand portfolio.”

The endocannabinoid system and the cannabinoids that modulate its activity are believed to have an important role in regulating skin health and skin disorders. The research will utilize Dr. Meiri’s cannabis strain database of over 80 cultivars and Cronos Group’s strain specific cannabis oils to isolate and investigate the effects of individual and combinations of cannabinoids, potentially including rare cannabinoids, for treating acne, psoriasis and wounds using stem cell-derived organoid cultures developed by Dr. Fuchs’ laboratory and mouse models. Cronos Group expects to be able to adapt the individual and combinations of cannabinoids to develop products for each of these three applications and expects to receive an exclusive, worldwide license to market and manufacture such products.

“We are pleased to partner with Cronos Group on this groundbreaking cannabinoid research,” said Dr. Fuchs. “Using our state of the art technology, we hope to unlock the vast therapeutic potential of cannabinoid formulations for treating skin disorders.”

“We are thrilled to begin this joint research with Dr. Meiri and Dr. Fuchs, who are among the most respected researchers in their fields,” said David Hsu, COO of Cronos Group. “Dr. Meiri’s extensive cannabis strain database and capabilities in analytical testing provide a strong foundation for researching Dr. Fuch’s world-renowned stem cell organoids. Dr. Meiri and Dr. Fuchs’ expertise coupled with Cronos Group’s competencies in the cannabis industry make us optimistic about the future opportunities from this collaboration.”

Canadians are invited to join the conversation: Raise Your Hand for Diabetes

By
IHR Magazine
-
0
Canadians are invited to join the conversation: Raise Your Hand for Diabetes

Sanofi Canada is on a mission to raise awareness and money to help people living with diabetes, one of the leading causes of death and disability in Canada.1 In honour of Diabetes Awareness Month, which begins on November 1, Sanofi Canada is calling upon Canadians to support Diabetes Canada and Diabète Québec with just one click of a button. For each new LIKE on the Raise Your Hand for Diabetes campaign’s Facebook page from November 1 until World Diabetes Day (November 14), Sanofi Canada will donate $5 to the associations, up to a maximum of $50,000.

Last week, Sanofi Canada got a head start on Diabetes Awareness Month efforts. At the Diabetes Canada/Canadian Society of Endocrinology and Metabolism Professional Conference, Sanofi Canada hosted a Raise Your Hand for Diabetes airstream in support of Diabetes Canada. Attendees shared their personal experiences with diabetes and their hopes for those living with the disease. For each testimony, Sanofi Canada made a donation, raising $25,000 for the association.

“The Raise Your Hand for Diabetes campaign aligns with Diabetes Canada’s mission to help people who are living with diabetes and to help work towards a cure. The campaign provides role models with everyday people choosing to use their voices to strike out the stigma against those living with diabetes. By doing so, they encourage people to admit that they are affected by diabetes, consequently making it easier to reach out and provide treatment,” said Russell Williams, Vice President Government Relations and Public Policy, Diabetes Canada.

Raise Your Hand for Diabetes is a unique awareness initiative that leverages patient and caregiver stories to create a community in which people living with diabetes play a direct role in dispelling the myths and stigma surrounding the disease. By visiting the website raiseyourhandfordiabetes.ca, Canadians can upload a video, picture or quote about what matters most on their personal diabetes journey. The website also provides a wealth of resources on diabetes management, including topics such as diet, physical exercise and treatment.

“To strike out diabetes, we must continue to raise awareness and help people better understand the disease. This campaign is a wonderful way to try and achieve the mission of decreasing the stigma and ultimately end diabetes,” said Dr. Alice Y.Y. Cheng, MD, FRCPC, Endocrinologist at Credit Valley Hospital and St. Michael’s Hospital and Associate Professor at the University of Toronto’s Department of Medicine.

“Sanofi Canada is proud to support people living with diabetes. Our Raise Your Hand for Diabetes initiative builds on a legacy that dates back almost 100 years to the 1920s, when the company, then known as Connaught Laboratories, worked with Doctors Banting, Best, Macleod and Collip on the first purification and large-scale production techniques for insulin. This helped turn diabetes into a manageable condition,” claimed Michael Mullette, President, Sanofi Canada. “We are committed to continuing to invest in research and to supporting those living with diabetes.”

First launched in Québec three years ago in partnership with Diabète Québec, Raise Your Hand for Diabetes has been expanded nationwide in collaboration with Diabetes Canada and STOP Diabetes Foundation.

 

 

 

—CNW

Loblaw and George Weston File Additional Information Regarding Spin-Out of Choice Properties REIT

By
IHR Magazine
-
0
Loblaw and George Weston File Additional Information Regarding Spin-Out of Choice Properties REIT

Loblaw Companies Limited and George Weston Limited announced that they have each filed disclosure materials containing additional information relating to the previously announced proposed reorganization by way of a plan of arrangement under which Loblaw will spin out its 61.6% interest in Choice Properties Real Estate Investment Trust.

Loblaw has filed the management proxy circular (the “Circular”) for its special meeting at which Loblaw shareholders will be asked to approve the proposed Arrangement. The meeting will be held at 11:00 a.m. (Toronto time) on Thursday, October 18, 2018, at the Metro Toronto Convention Centre, Meeting Room 714AB, South Building, 22 Bremner Boulevard, Toronto, Ontario, M5V 3L9. The notice of meeting and Circular has been mailed to Loblaw shareholders of record as at September 17, 2018. Loblaw shareholders are encouraged to vote as early as possible and in any event prior to 4:00 p.m.(Toronto time) on October 15, 2018.

The Board of Directors of Loblaw has unanimously determined that the Arrangement is in the best interests of Loblaw and recommends that Loblaw shareholders vote FOR the special resolution approving the Arrangement.

Loblaw shareholders who have questions regarding the meeting or require assistance with voting may contact Kingsdale Advisors by toll‐free telephone in North America at 1‐866‐228-2532, by collect call outside North America at 1-416‐867‐2272, or by email at contactus@kingsdaleadvisors.com.

GWL has also filed an information statement providing supplemental information relating to the proposed Arrangement. The information statement has been prepared for informational purposes only and GWL shareholders do not need to take any action.

The Circular and GWL information statement is available on Loblaw’s and GWL’s respective SEDAR profiles (www.sedar.com) and websites (www.loblaw.ca or www.weston.ca).

Approvals and Closing Conditions
Subject to the approval of the Arrangement by the Loblaw shareholders, the final hearing of the Ontario Superior Court of Justice (Commercial List) to approve the Arrangement is scheduled to take place on October 19, 2018, at 10:00 a.m.(Toronto time) at 330 University Avenue, Toronto, Ontario. Participation in the hearing, including who may participate and the procedure for doing so, is subject to the terms of the interim order in respect of the Arrangement, a copy of which is attached to the Circular. Copies of the notice of application for the final order are available on request by contacting Loblaw.

In addition to Loblaw shareholder and court approvals, the Arrangement is subject to customary conditions, including approval by the Toronto Stock Exchange and receipt of an advance tax ruling from the Canada Revenue Agency. Loblaw and GWL anticipate that the Arrangement will be completed in the fourth quarter of 2018.

—CNW

Canadian Federation of Independent Grocers Releases 2018 Financial Survey

By
IHR Magazine
-
0
Canadian Federation of Independent Grocers Releases 2018 Financial Survey

FMS Financial Management Systems LTD and Canadian Federation of Independent Grocers release 2018 Canadian Independent Financial Survey.

Profits held steady at 1.5% of sales and EBITDA increased to 1.8%.  Labor expense increased by .7%.   This cost increase was anticipated given legislated wage hikes in some areas in late 2017 and early 2018.  However gross margin performance was strong as respondents realized 1.9% year over year growth.  Depreciation was up .4% the prior year which factors into the EBITDA growth.

Food inflation for the survey period was +1.6%.   The survey results, however, yielded a .3% decrease meaning sales decreased in real dollars by 1.9% year over year.    Notably, Quebec and Ontario posted positive gains of 1.1% and 0.6% respectively before adjustments for food inflation.

The battle for top-line sales continues to escalate and we were surprised to note 70% of respondents do not have an online ordering offering.  “Click and pick” is the most popular form of online shopping amongst the balance of respondents.  As retailers try to grow sales and retain parity with competitors.  The ‘click and pick’ online solution offers a quicker rollout and is a much lower cost alternative compared to online shopping coupled with delivery.

Overall survey results were positive.  Independents are faring well in an increasingly competitive landscape.  Additionally, retailers have had to absorb the cost of legislated wage hikes.   Stable profit, improved EBITDA, and margin growth reflect the resilience of the independent retailer segment.   Growing top line and managing labour will be the key to success as we move forward.   Understanding labour metrics and continued increases in labour efficiency coupled with adopting a viable online shopping platform will be crucial.   Robert Graybill of FMS stated, “It will be critical that retailers develop good labour management solutions and begin to research the feasibility and payback of investing in online ordering as this is the next real threat to top line sales.”

 

 

—CNW

Wayland Signs Huge Supply Agreement with Cannamedical Product from Canada to Germany

By
IHR Magazine
-
0
Wayland Signs Huge Supply Agreement with Cannamedical Product from Canada to Germany

Wayland Group is pleased to announce that it has entered into an agreement to supply Cannamedical Pharma GmbH, a licensed, privately owned importer and distributor of cannabis in Germany to over 2,200 pharmacies with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three-year term. The companies have completed mandatory quality assurance and control audits and have scheduled the first shipment in December of 2018.

“The decision we made in early 2017 to move to EU-GMP standards for all production, including cannabis flowers, followed by certification in the spring of this year by the German Health Authorities, provides the Company with the opportunity to move a significant amount of product, in this case, 9,000 kilograms to Germany. We’re proud to be one of six companies worldwide out of thousands of cannabis producers who can say we pass the test and exceed EU-GMP standards for dry cannabis flowers.  This agreement will provide meaningful revenue and profit to the Company over the next three years as we build a sustainable business,” stated Ben Ward, CEO of Wayland.

“We are pleased to enter into this agreement with Wayland. Being able to meet the exponentially growing demand of our European client base strengthens our position as the largest independent and privately-owned cannabis distributor in Germany. Cannamedical will formally introduce its CannaSativa®, CannaIndica® and Cannahybrid® product lines during next week’s German pain congress in Mannheim, Germany,” stated David Henn, CEO of Cannamedical.

About Wayland Group: Wayland is a vertically integrated producer and distributor of marijuana for medical purposes. The company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) footprint upon full buildout and will continue to pursue new opportunities in Europe.

About Cannamedical: Cannamedical has been one of the first to specialize in highly efficient pharma distribution and marketing in accordance with the narcotics regulations in Germany. The privately-owned, GDP certified company holds all licenses required for medical cannabis import to Germany, distribution and export within the European Union. Serving a growing network of 2.200 German pharmacies from a centrally located, GMP certified storage facility, Cannamedical is well positioned to expand its footprint within European Union medical Cannabis market. For more information about Cannamedical, please visit our website at www.cannamedical.com —Global

Study Says Canadians would like Cannabis Edibles

By
IHR Magazine
-
0
Study Says Canadians would like Cannabis Edibles

—by Toni-Marie Ippolito

With the legalization of cannabis now in effect,  Canadians still have questions when it comes where to get it and how they can take the product.

If you’re not a smoker, chances are you may prefer to consume cannabis, whether it’s for recreational or medicinal purposes, in edible form. In fact, a recent study from Dalhousie University says that Canadians want to try edible marijuana products. The big “but” here is that cannabis edibles are not legal for sale to customers.

The Dalhousie University study found that 46 per cent of Canadians would try cannabis-infused food products if they became available on the market. Thirty-nine per cent would be willing to try it in a restaurant, but only 20 per cent said that they know enough about cooking with marijuana to do it at home. However, 59 per cent worry about the risk that legalizing the use of recreational marijuana poses for children and young adults who will have increased access to it.

The preliminary study, entitled “Cannabis-infused food and Canadian consumers’ willingness to consider recreational marijuana as a food ingredient” was led by Dr. Sylvain Charlebois, professor in food distribution and policy at the Faculty of Management at Dalhousie University and lead author of Canada’s Food Price Report and Dr. Simon Somogyi, associate professor in the Faculty of Agriculture at Dalhousie.

A total of 1087 people took part in the survey, conducted in English and French over four weeks in August 2017. The survey shows that the majority of Canadians (68 per cent) are supportive of legalizing marijuana for recreational purposes, with British Columbians being the most supportive (79 per cent) and people on the Prairies being the least (54 per cent).

The Federal government of Canada legalized the recreational use of marijuana on July 1, 2018. However, Bill C-45, also known as the Cannabis Act, does not include the legalization of edible products, such as marijuana-infused baked goods. This means Canadians will not be able to purchase cannabis-infused goods such as cookies, brownies and candy, etc.

The federal government has said that it plans to deal with such products, which are commonly known as “edibles,” at a later date, but that only dried cannabis, fresh cannabis, cannabis plants, cannabis seeds and cannabis oil will be legally available for purchase. You can, however, make edibles yourself for your own consumption.

“People are interested in cooking with marijuana, but they don’t yet know how,” says Charlebois. “However, younger people and those from higher-income households are more likely to feel confident in their abilities.” Baked goods, oils and spices are among the products survey respondents said they’d be interested in trying.

Although cannabis edibles are currently prohibited under the Cannabis Act Charlebois says consumers want them. “It’s short-sighted,” says Charlebois says of the fact that edibles are not yet legal. “Our study shows that the majority of Canadians are willing to purchase them, and edibles are Health Canada’s recommended consumption form for cannabis.”

 

 

Green Relief Inc. to use Aquaponics Technology to Grow Medical Cannabis

By
IHR Magazine
-
0
Green Relief Inc. to use Aquaponics Technology to Grow Medical Cannabis

Green Relief Inc., a licensed producer of medical cannabis in Flamborough, Ontario, has become the world’s leading expert on growing cannabis on a commercial scale using aquaponics.

Aquaponics is a sustainable form of agriculture where fish and plants are grown together in a natural ecosystem-based environment. Aquaponics combines the best attributes of aquaculture and hydroponics without the use of chemical additives or having to discard harmful water into the environment. It can produce more than ten times the crop yield per acre and uses 90% less water than conventional farming.

With the natural resources of our planet being depleted at an alarming rate, Green Relief believes in striving to embed sustainability in every fiber of its company through awareness, involvement, and innovation. They incorporate strong environmental, health, and social values in everything they do from the geothermal advantage of their earth-sheltered building to the 100% use of energy-saving LED lights and environmentally responsible aquaponic growing systems. From their planned integration of job positions for the physically disabled through the Ontario Disability Employment Network to donating organically fed tilapia to the local homeless shelters for people in need.

Green Relief’s team of exceptional horticulturalists, scientists, and aquaponic specialists are committed to and actively engaged in the company’s mandate for sustainability. It’s this greater purpose that has created such a powerful company culture where all the employees are personally engaged in a process where they can actually see how they are improving peoples’ lives and making a difference in the world. Exceptional people growing an exceptional plant.

At Green Relief, the cannabis plants are propagated from carefully selected mother plants that are replaced regularly to ensure that the strong genetics of each strain is maintained for optimum cannabinoid and terpene production. This ensures that medical cannabis is consistent from batch to batch resulting in a dependable and high-quality product. Carefully tracked batches of each plant strain are harvested every two weeks to ensure maximum freshness, quality, and traceability is maintained for their patients.

The highly qualified Quality Assurance team at Green Relief ensures that all procedures and protocols are strictly applied during the growing, harvesting, drying, and extracting processes for their medical cannabis. All their products undergo strict testing by both their in-house scientists and third-party laboratories. Products are tested for potency levels as well as for microbiological contaminants, heavy metals, pesticides, and aflatoxins to ensure that patients are receiving a safe and consistent product in every order.

Warren Bravo is the co-founder and CEO of Green Relief Inc., a licensed producer devoted to bringing innovation and social responsibility to the medical cannabis industry, took a leap of faith to establish Green Relief Inc. with co-founder Steve LeBlanc. Their mission: help patients improve their quality of life while furthering the science of medical cannabis and sustainable agriculture around the world.

Recently, Green Relief has expanded its operations by acquiring a 100,000 sq.ft. facility in nearby Stoney Creek, Ontario, providing a real boost to the local economy. The facility, which will contain 75,000 sq. ft. of growing area and 25,000 sq. ft. of office space, allows Green Relief to grow its medicinal products on a much larger scale. The building will act as an extension of the company’s headquarters in Flamborough and includes plans for installing a second floor, which will double the production output. Green Relief will be hosting a job fair in the coming months and is very excited to be expanding employment opportunities in the Stoney Creek area by creating approximately 100 new living wage jobs. Green Relief also plans to go public giving an initial public offering (IPO) in the coming months.

Cannabis Canada: Canadian Parents agree not enough Info available to youth on risks

By
IHR Magazine
-
0
Cannabis Canada: Canadian Parents agree not enough Info available to youth on risks

According to a survey commissioned by Organigram Inc., a leading licensed producer of medical marijuana, a majority of Canadian parents (60 per cent) are concerned about cannabis legalization.

More than half of the parents surveyed (54 per cent) feel there is currently not enough information available to youth about the risks associated with cannabis use and only three in ten parents feel “very prepared” to educate their children about cannabis.

“As we move toward the legalization of cannabis, it’s important that we take pulse checks along the way,” said Ray Gracewood, Chief Commercial Officer, Organigram. “By asking parents how they feel, we get a real-time sense of not only what’s keeping Canadian parents up at night, but the opportunities we have, as a company and as an industry, and in collaboration with healthcare professionals and educators, to address their concerns. If the safety of youth is a priority of legalization, this discussion is critical.”

The survey also revealed that nearly half of parents (46 per cent) with children aged four and up have already discussed cannabis legalization with their children, though only one-quarter (26 per cent) of that group have discussed this in detail. One in ten (9 per cent) do not plan on discussing legalization with their children.

One-third of all parents (35 per cent) feel “very confident” they could recognize signs of cannabis use in their child. Two-thirds of parents (67 per cent) are most trusting of physicians or other healthcare professionals when it comes to information to help parents educate children about cannabis and its appropriate use.

Canadian parents feel it is important to have information on topics relating to: the perception that cannabis use leading to the use of “harder” drugs (84 per cent); the comparative effects of different forms of cannabis (e.g. edibles compared to smoking cannabis) (88 per cent); and the likelihood of cannabis use leading to tobacco use (74 per cent).

When asked about the education of youth about cannabis, the top priority that parents identified from a list of potential priorities for children is the importance of not driving under the influence of cannabis (87 per cent). Other top priorities include the negative effects of cannabis use on their bodies (75 per cent), how to turn down offers to use it (75 per cent), and risks of use with other substances (74 per cent).

“Legalization is coming and this research highlights the fact that Canadian parents have concerns,” said Dr. Michael Verbora, Chief Medical Officer of Aleafia Total Health. “Ask yourself: what are your concerns? I would encourage parents to seek information on the risks and realities from a credible source, like a physician or health authority, and start having those conversations now. Knowledge is power and will be key to proactive, open dialogue in Canadian homes. Frank discussion and well-informed families will help protect youth in this new era of legalization.”

While Canadian parents are aligned on many of their concerns and priorities, there are notable differences across regions. For example, Current reported cannabis use is highest among Atlantic Canadian parents (20 per cent) and British Columbian parents (16 per cent), and potential reported use is also highest among Atlantic Canadian parents (22 per cent). Having never used cannabis and having no intention to use it is reported as highest among parents in Quebec (43 per cent) and parents in Ontario (42 per cent).

Atlantic Canadian parents are most likely of all regions to strongly support legalization (39 per cent), to not be concerned about legalization (52 per cent) and to feel very prepared to educate their children about cannabis (43 per cent).

Quebecois parents are those most likely of parents in all regions to strongly oppose legalization (35 per cent), to be concerned about legalization (69 per cent), and do not feel prepared to educate their children about it (37 per cent).

Atlantic Canadian parents and parents from the Prairies are those most likely of parents in all regions to feel very confident that they could recognize signs of use in their children (44 per cent and 40 per cent, respectively).

Ontarian parents are more likely than those in other regions to trust the following sources for education: physicians/healthcare professionals, the provincial government, and the federal government.

As a company committed to the education of youth and young adults, Organigram says, “The most important goal of cannabis legalization is the protection of Canadian youth,” says Greg Engel, CEO, Organigram. “As a company, we will continue to support the education of Canadians about cannabis and will continue to collaborate with those on the front lines of this discussion.”  —OrganiGram

1...139140141...389Page 140 of 389

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© 2026 IHR Magazine | Canada's Natural Health Industry Authority | Le guide de l’industrie canadienne de la santé naturelle